Professor Colin Fishwick
- Position: Professor
- Areas of expertise: Medicinal chemistry; synthetic methods; chemical biology; drug design; molecular modelling.
- Email: C.W.G.Fishwick@leeds.ac.uk
- Phone: +44(0)113 343 6510
- Location: G.26 School of Chemistry
- Website: Personal homepage | Astbury Centre
Profile
I received my undergraduate degree in Chemistry from the University of Liverpool, graduating with First Class Honours in 1982. I went on to carry out my PhD there from 1982-1985 before joining the staff at University of Leeds in 1985. I was appointed to a Chair in Medicinal Chemistry in 2009. I am currently Professor of Medicinal Chemistry at the University of Leeds and Honorary Visiting Professor of Medicinal Chemistry at the University of Bradford, Institute of Cancer Therapeutics and at the University of Sheffield. I have authored more than 140 publications. In 2019, I took up the post of Head of the School of Chemistry at Leeds.
Responsibilities
- Head of School
Research interests
Computer-aided design and subsequent synthesis of drug-like moleculesdirected against important therapeutic targets including antibacterial, antimalarial, antithrombotic, anti-Alzheimer's agents and anti-cancer agents. Use of synthetic 'probe' molecules in the study of biological structure and function.
<h4>Research projects</h4> <p>Any research projects I'm currently working on will be listed below. Our list of all <a href="https://eps.leeds.ac.uk/dir/research-projects">research projects</a> allows you to view and search the full list of projects in the faculty.</p>Qualifications
- PhD, University of Liverpool
- BSc, University of Liverpool
Professional memberships
- Editorial Board, Scientific Reports
- Editorial Board, ACS Infectious Diseases
- Editorial Board, European Journal of Medicnal Chemistry
Student education
As well as being Head of School, I teach organic and medicinal chemistry at all levels.
Research groups and institutes
- Chemical Biology and Medicinal Chemistry
Projects
-
<li><a href="//phd.leeds.ac.uk/project/519-licamm-repurposing-bace1-inhibitors-for-cardiovascular-disease">LICAMM Repurposing BACE1 inhibitors for cardiovascular disease</a></li>